Search results
Genetics in Hypertrophic Cardiomyopathy
Author(s):
María Noël Brögger
,
Ivonne Johana Cárdenas Reyes
,
Soledad García Hernández
,
et al
Added:
1 month ago
Review Article
Important Gaps in Heart Failure Care
Author(s):
Zara Latif
,
Tracy Makuvire
,
Sarah Schroeder
,
et al
Added:
4 months ago
Review Article
MY-MDHFC Study
Author(s):
Hwei Sung Ling
,
Bui Khiong Chung
,
Alan Yean Yip Fong
,
et al
Added:
2 weeks ago
Original Research
Author(s):
Michael Kiernan
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure…
View more
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
1 year ago
Dimitris Tsiachris
Job title: Interventional Electrophysiologist
Author
Aldosterone and Potassium in Heart Failure
Author(s):
Laibah Arshad Khan
,
Adeena Jamil
,
Stephen J Greene
,
et al
Added:
1 year ago
Review Article
Author(s):
Michel Komajda
Added:
1 year ago
Author(s):
Julian Gillmore
,
Margot K Davis
Added:
7 months ago
This programme, featuring Prof Julian Gillmore (University College London, London, UK) and Dr Margot Davis (Vancouver General Hospital, Vancouver, CA) offers an in-depth exploration of ATTR amyloidosis, highlighting the value of observational research in understanding disease presentation, treatment patterns, and outcomes. Viewers will learn about the pathophysiology and spectrum of the condition…
View more
Author(s):
Deepak L Bhatt
Added:
1 week ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO…
View more